{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:35:54Z","timestamp":1791272154164,"version":"4.1.0"},"reference-count":46,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>No antiviral drugs currently exist for the treatment of enterovirus infections, which are often severe and potentially life threatening. Molecular screening of small molecule libraries identified fluoxetine, a selective serotonin reuptake inhibitor, as a potent inhibitor of coxsackievirus replication. Fluoxetine did not interfere with either viral entry or translation of the viral genome. Instead, fluoxetine and its metabolite norfluoxetine markedly reduced the synthesis of viral RNA and protein. In view of its favorable pharmacokinetics and safety profile, fluoxetine warrants additional study as a potential antiviral agent for enterovirus infections.<\/jats:p>","DOI":"10.1128\/aac.00983-12","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T02:37:25Z","timestamp":1341283045000},"page":"4838-4844","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":96,"title":["Fluoxetine Is a Potent Inhibitor of Coxsackievirus Replication"],"prefix":"10.1128","volume":"56","author":[{"given":"Jun","family":"Zuo","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin K.","family":"Quinn","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Kye","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Damoiseaux","sequence":"additional","affiliation":[{"name":"California Nanosystems Institute, University of California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Krogstad","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California, Los Angeles, California, USA"},{"name":"Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1177\/106002809202601205","article-title":"Abnormal platelet aggregation associated with fluoxetine therapy","volume":"26","author":"Alderman CP","year":"1992","unstructured":"AldermanCP MoritzCK Ben-TovimDI. 1992. Abnormal platelet aggregation associated with fluoxetine therapy. Ann. Pharmacother. 26:1517\u20131519.","journal-title":"Ann. Pharmacother."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.11.8482-8489.1997"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02244958","article-title":"Fluoxetine: a review of receptor and functional effects and their clinical implications","volume":"107","author":"Beasley CM","year":"1992","unstructured":"BeasleyCM MasicaDN PotvinJH. 1992. Fluoxetine: a review of receptor and functional effects and their clinical implications. Psychopharmacology (Berl.) 107:1\u201310.","journal-title":"Psychopharmacology (Berl.)"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.12.9969-9975.1999"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0904.020395"},{"key":"e_1_3_2_7_2","first-page":"553","article-title":"Increased detections and severe neonatal disease associated with coxsackievirus B1 infection\u2014United States, 2007","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","unstructured":"Centers for Disease Control and Prevention. 2008. Increased detections and severe neonatal disease associated with coxsackievirus B1 infection\u2014United States, 2007. MMWR Morb. Mortal. Wkly. Rep. 57:553\u2013556.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_8_2","first-page":"1577","article-title":"Nonpolio enterovirus and human parechovirus surveillance\u2014United States, 2006\u20132008","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention. 2010. Nonpolio enterovirus and human parechovirus surveillance\u2014United States, 2006\u20132008. MMWR Morb. Mortal. Wkly. Rep. 59:1577\u20131580.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_9_2","first-page":"1984","volume-title":"Textbook of pediatric infectious diseases","author":"Cherry JD","year":"2009","unstructured":"CherryJD KrogstadPK. 2009. Enteroviruses and parechoviruses, p 1984\u20132041. In FeiginRD CherryJD DemmlerGJ KaplanS (ed), Textbook of pediatric infectious diseases, 6th ed. WB Saunders Co., Philadelphia, PA.","edition":"6"},{"key":"e_1_3_2_10_2","first-page":"32","article-title":"A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder","volume":"46","author":"Chouinard G","year":"1985","unstructured":"ChouinardG. 1985. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. J. Clin. Psychiatry 46:32\u201337.","journal-title":"J. Clin. Psychiatry"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/jmv.10138","article-title":"Development and evaluation of a \u2018real-time\u2019 RT-PCR for the detection of enterovirus and parechovirus RNA in CSF and throat swab samples","volume":"67","author":"Corless CE","year":"2002","unstructured":"CorlessCE . 2002. Development and evaluation of a \u2018real-time\u2019 RT-PCR for the detection of enterovirus and parechovirus RNA in CSF and throat swab samples. J. Med. Virol. 67:555\u2013562.","journal-title":"J. Med. Virol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archinte.163.1.59","article-title":"Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study","volume":"163","author":"Dalton SO","year":"2003","unstructured":"DaltonSO . 2003. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch. Intern. Med. 163:59\u201364.","journal-title":"Arch. Intern. Med."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/med.20125"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.9.4430-4440.2002"},{"key":"e_1_3_2_15_2","first-page":"59","volume-title":"The picornaviruses","author":"Fry EE","year":"2010","unstructured":"FryEE StuartDI. 2010. Virion structure, p 59\u201372. In EhrenfeldDE RoosRP (ed), The picornaviruses. ASM Press, Washington, DC."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2165\/11534720-000000000-00000","article-title":"Fluoxetine disposition in patients with chronic hepatitis C treated with interferon-alpha","volume":"49","author":"Furlanut M","year":"2010","unstructured":"FurlanutM SoardoG DonniniD SechiL FranceschiL. 2010. Fluoxetine disposition in patients with chronic hepatitis C treated with interferon-alpha. Clin. Pharmacokinet. 49:767\u2013772.","journal-title":"Clin. Pharmacokinet."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2008.03.012"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.antiviral.2007.12.009","article-title":"Rapid identification of inhibitors that interfere with poliovirus replication using a cell-based assay","volume":"77","author":"Hwang YC","year":"2008","unstructured":"HwangYC ChuJJ YangPL ChenW YatesMV. 2008. Rapid identification of inhibitors that interfere with poliovirus replication using a cell-based assay. Antiviral Res. 77:232\u2013236.","journal-title":"Antiviral Res."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/QAD.0b013e328339d004","article-title":"Predictors and treatment strategies of HIV-related fatigue in the combined antiretroviral therapy era","volume":"24","author":"Jong E","year":"2010","unstructured":"JongE . 2010. Predictors and treatment strategies of HIV-related fatigue in the combined antiretroviral therapy era. AIDS 24:1387\u20131405.","journal-title":"AIDS"},{"key":"e_1_3_2_20_2","first-page":"1","article-title":"Enterovirus surveillance\u2014United States, 1970\u20132005","volume":"55","author":"Khetsuriani N","year":"2006","unstructured":"KhetsurianiN Lamonte-FowlkesA OberstS PallanschMA. 2006. Enterovirus surveillance\u2014United States, 1970\u20132005. MMWR Surveill. Summ. 55:1\u201320.","journal-title":"MMWR Surveill. Summ."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.11.7811-7818.1996"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/INF.0b013e31816b5d2a","article-title":"Fatal neonatal myocarditis caused by a recombinant human enterovirus-B variant","volume":"27","author":"Krogstad P","year":"2008","unstructured":"KrogstadP HammonR HalnonN WhittonJL. 2008. Fatal neonatal myocarditis caused by a recombinant human enterovirus-B variant. Pediatr. Infect. Dis. J. 27:668\u2013669.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1503\/cmaj.100912","article-title":"Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction","volume":"183","author":"Labos C","year":"2011","unstructured":"LabosC DasguptaK NedjarH TureckiG RahmeE. 2011. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ 183:1835\u20131843.","journal-title":"CMAJ"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pnpbp.2012.03.011","article-title":"Psychotropic drug effects on gene transcriptomics relevant to Parkinson's disease","volume":"38","author":"Lauterbach EC","year":"2012","unstructured":"LauterbachEC. 2012. Psychotropic drug effects on gene transcriptomics relevant to Parkinson's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 38:107\u2013115.","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/INF.0b013e3181e52945","article-title":"An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features","volume":"29","author":"Lee MS","year":"2010","unstructured":"LeeMS . 2010. An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features. Pediatr. Infect. Dis. J. 29:1030\u20131034.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_26_2","first-page":"14","article-title":"Fluoxetine: clinical pharmacology and physiologic disposition","volume":"46","author":"Lemberger L","year":"1985","unstructured":"LembergerL . 1985. Fluoxetine: clinical pharmacology and physiologic disposition. J. Clin. Psychiatry 46:14\u201319.","journal-title":"J. Clin. Psychiatry"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(00)00068-8"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"e775","DOI":"10.1016\/j.ijid.2010.02.2265","article-title":"The enterovirus 71 epidemic in 2008\u2014public health implications for Hong Kong","volume":"14","author":"Ma E","year":"2010","unstructured":"MaE ChanKC ChengP WongC ChuangSK. 2010. The enterovirus 71 epidemic in 2008\u2014public health implications for Hong Kong. Int. J. Infect. Dis. 14:e775\u2013e780.","journal-title":"Int. J. Infect. Dis."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.coph.2011.01.008","article-title":"MicroRNA in the regulation and expression of serotonergic transmission in the brain and other tissues","volume":"11","author":"Millan MJ","year":"2011","unstructured":"MillanMJ. 2011. MicroRNA in the regulation and expression of serotonergic transmission in the brain and other tissues. Curr. Opin. Pharmacol. 11:11\u201322.","journal-title":"Curr. Opin. Pharmacol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.035"},{"key":"e_1_3_2_31_2","first-page":"33","article-title":"Comparative genomics of the coxsackie B viruses and related enteroviruses","volume":"323","author":"Oberste M","year":"2008","unstructured":"ObersteM. 2008. Comparative genomics of the coxsackie B viruses and related enteroviruses. Curr. Top. Microbiol. Immunol. 323:33\u201347.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.2.855-867.2004"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.6.2948-2955.2004"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.11.6992"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1086\/318452"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/art.27304","article-title":"Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors","volume":"62","author":"Sacre S","year":"2010","unstructured":"SacreS MedghalchiM GregoryB BrennanF WilliamsR. 2010. Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors. Arthritis Rheum. 62:683\u2013693.","journal-title":"Arthritis Rheum."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.5.2377-2387.2001"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.08.016"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2011.03.187"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.23.12097-12111.2002"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.11.4729-4735.1989"},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0168-1702(03)00136-9","article-title":"Cell cycle regulation of hepatitis C and encephalomyocarditis virus internal ribosome entry site-mediated translation in human embryonic kidney 293 cells","volume":"94","author":"Venkatesan A","year":"2003","unstructured":"VenkatesanA SharmaR DasguptaA. 2003. Cell cycle regulation of hepatitis C and encephalomyocarditis virus internal ribosome entry site-mediated translation in human embryonic kidney 293 cells. Virus Res. 94:85\u201395.","journal-title":"Virus Res."},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1086\/605089"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)36118-5"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1284"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1086\/605090","article-title":"Increased activity of Coxsackievirus B1 strains associated with severe disease among young infants in the United States, 2007\u20132008","volume":"49","author":"Wikswo ME","year":"2009","unstructured":"WikswoME . 2009. Increased activity of Coxsackievirus B1 strains associated with severe disease among young infants in the United States, 2007\u20132008. Clin. Infect. Dis. 49:e44\u2013e51.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1177\/108705719900400206"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00983-12","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00983-12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:08:40Z","timestamp":1645481320000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00983-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.1128\/AAC.00983-12"],"URL":"https:\/\/doi.org\/10.1128\/aac.00983-12","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"2012-05-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-06-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-08-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}